Influence of body mass index and type of low-level exercise on the side effect profile of regadenoson

Purpose Regadenoson, an A 2A adenosine receptor pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI), is administered as a single, fixed dose. We studied the side effect profile of regadenoson combined with two types of low-level exercise, according to body mass index (BMI)...

Full description

Saved in:

Bibliographic Details
Published in:	European journal of nuclear medicine and molecular imaging Vol. 44; no. 11; pp. 1906 - 1914
Main Authors:	Salgado-Garcia, Carlos, Jimenez-Heffernan, Amelia, Lopez-Martin, Juana, Molina-Mora, Manuela, Aroui, Tarik, Sanchez de Mora, Elena, Ramos-Font, Carlos, Rivera de los Santos, Francisco, Ruiz-Frutos, Carlos
Format:	Journal Article
Language:	English
Published:	Berlin/Heidelberg Springer Berlin Heidelberg 01-10-2017 Springer Nature B.V
Subjects:	Blood pressure Body mass Body mass index Body weight Cardiology Demographics Demography Discomfort Echocardiography EKG Flushing Heart rate Imaging Incidence Legs Levels Medicine Medicine & Public Health Men Nausea Nuclear Medicine Oncology Original Article Orthopedics Overweight Oxygen content Patients Perfusion Pharmaceuticals Pharmacology Physical training Radioisotopes Radiology Risk factors Saturation Side effects Stress Stresses Walking Body mass index Side effects Myocardial perfusion imaging Regadenoson Safety Low-level exercise
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!